Home › Funds › BlackRock Inc › VRTX
BlackRock Inc position in VRTX
VERTEX PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)24.11M sh
Reported value held$11.98B
Portfolio Weight0.19%
First reportedQ3 2024
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 21.79M | $10.13B | New |
| Q4 2024 | 21.83M | $8.79B | Hold |
| Q1 2025 | 21.78M | $10.56B | Hold |
| Q1 2025 | 21.78M | $10.56B | Hold |
| Q2 2025 | 21.87M | $9.74B | Hold |
| Q2 2025 | 21.87M | $9.74B | Hold |
| Q3 2025 | 22.25M | $8.72B | Add |
| Q4 2025 | 23.75M | $10.77B | Add |
| Q1 2026 | 23.97M | $10.70B | Add |
| Q2 2026 | 24.11M | $11.98B | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VRTX
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- Vanguard Group 24.11M sh · $10.93B · Q4 2025
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Invesco Ltd 8.04M sh · $4.00B · Q2 2026
- Geode Capital Management 6.02M sh · $2.98B · Q2 2026
- Franklin Resources 3.35M sh · $1.66B · Q2 2026
- Wellington Management Group 3.25M sh · $1.61B · Q2 2026
- Morgan Stanley 3.24M sh · $1.61B · Q2 2026
- Bank of America Corp 3.04M sh · $1.51B · Q2 2026
- Norges Bank Investment Management 2.97M sh · $1.48B · Q2 2026
- Northern Trust Corp 2.49M sh · $1.24B · Q2 2026